Medtronic HMS Plus Manuel De L'utilisateur page 154

HMS_Plus_EN_9.fm 4/17/12 6:44 pm
8.5 x 11.0 inches (215.9 mm x 279.4 mm)
Chapitre 9
Mochizuki T, Olson PJ, Ramsay JG, Szlam F, Levy JH. Does excess protamine
reversal of heparin affect coagulation after cardiopulmonary bypass? Anesth Analg.
1997:84:36.
Moorthy S, Pond W. Severe circulatory shock following protamine (an anaphylactic
reaction). Anesth Analg. 1980;59:77.
Niinikoski J, Laato M, Eaaksonen V, Jalonen J, Inberg MV. Use of activated
clotting time to monitor anticoagulation during cardiopulmonary bypass. J Thorac
Cardiovasc Surg. 1984;81:378.
Pifarre R, Babka R, Sullivan HJ, Montoya A, Bakos M, El Etr A. Management of
postoperative heparin rebound following cardiopulmonary bypass. J Thorac
Cardiovasc Surg. 1981;81:378.
Saleem A, Shenaq SS, Yawn DH, Harshberger K, Dienumsch P, Mohindra P.
Heparin monitoring during cardiopulmonary bypass. Ann Clin Lab Sci. 1984;14:474.
Schlueter AJ, Pennell BJ, Olson JD. Evaluation of a new protamine titration method
to assay heparin in whole blood and plasma. Am J Clin Path. 1997;107:511.
Thomas SJ, Gitel SN, Starr NJ, Culliford AT, Wessler S. Activated clotting time and
heparin levels during hypothermic cardiopulmonary bypass. Anesthesiology.
1981;53:S115.
Wakefield TW, Hantler CB, Lindblad B, Whitehouse WM, Stanley JC. Protamine
pretreatment attenuation of hemodynamic and hematologic effects of
heparin-protamine interaction. J Vasc Surg. 1986;3:885.
9-4 Manuel de l'utilisateur HMS Plus
86508002 Rev. 1A
Medtronic Confidential
CS0026